Table 3.
Treatment outcomes in different treatment groups after imputation: Primary outcomes.
Available data | Intent to treat data | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tbaseline | Tpost-treatment | Tpost-treatment | ||||||||||||
Measure | Group | N | M(SD) | N | M(SD) | da | p | N | M(SD) | da | p | ANOVAb | Factor | p |
PCL-C Total score | DBT-PTSD | 39 | 65.6 (7.59) | 20 | 48.7 (13.5) | 1.38 | <.001 | 39 | 55.8 (13.3) | 0.71 | <.001 | F(1,134) = 55.01 | Time | <.001 |
TAU | 97 | 61.8 (10.5) | 60 | 56.1 (11.3) | 0.70 | <.001 | 97 | 58.2 (11.4) | 0.50 | <.001 | F(1,134) = 0.172 | Group | .679 | |
dc | 0.49 | .05 | 0.19 | .32 | F(1,134) = 11.54 | Gr. x ti. | <.001 | |||||||
PCL-C Re-experiencing | DBT-PTSD | 39 | 3.81 (0.74) | 20 | 2.95 (0.99) | 0.93 | <.001 | 39 | 3.32 (0.97) | 0.56 | .001 | F(1,134) = 20.15 | Time | <.001 |
TAU | 97 | 3.72 (0.93) | 60 | 3.59 (0.84) | 0.21 | .12 | 97 | 3.62 (0.89) | 0.16 | .12 | F(1,134) = 0.490 | Group | .485 | |
dc | 0.61 | .02 | 0.34 | .08 | F(1,134) = 9.07 | Gr. x ti. | .003 | |||||||
PCL-C Numbing/avoidance | DBT-PTSD | 39 | 5.18 (0.73) | 20 | 3.73 (1.19) | 1.50 | <.001 | 39 | 4.31 (1.20) | 0.74 | <.001 | F(1,134) = 20.15 | Time | <.001 |
TAU | 97 | 4.67 (0.94) | 60 | 4.41 (0.89) | 0.41 | .002 | 97 | 4.49 (1.02) | 0.32 | .002 | F(1,134) = 0.490 | Group | .485 | |
dc | 0.50 | .05 | 0.17 | .37 | F(1,134) = 9.07 | Gr. x ti. | .003 | |||||||
PCL-C Hyperarousal | DBT-PTSD | 39 | 4.27 (0.78) | 20 | 3.13 (1.15) | 1.29 | <.001 | 39 | 3.63 (1.14) | 0.66 | <.001 | F(1,134) = 49.39 | Time | <.001 |
TAU | 97 | 4.17 (0.81) | 60 | 3.78 (0.89) | 0.68 | <.001 | 97 | 3.92 (0.87) | 0.49 | <.001 | F(1,134) = 0.430 | Group | .513 | |
dc | 0.56 | .03 | 0.32 | .10 | F(1,134) = 10.30 | Gr. x ti. | .002 | |||||||
DES-II | DBT-PTSD | 41 | 42.1 (20.6) | 20 | 31.3 (17.9) | 0.98 | <.001 | 41 | 34.7 (20.1) | 0.56 | <.001 | F(1,135) = 14.01 | Time | <.001 |
TAU | 96 | 31.5 (17.4) | 59 | 30.3 (18.0) | 0.06 | .632 | 96 | 31.0 (18.4) | 0.05 | .631 | F(1,135) = 4.71 | Group | .032 | |
dc | 0.05 | .853 | 0.20 | .291 | F(1,135) = 10.59 | Gr. x ti. | .001 | |||||||
PTCI total score | DBT-PTSD | 39 | 148.0 (29.8) | 20 | 115.4 (45.3) | 1.31 | <.001 | 39 | 124.6 (40.8) | 0.69 | <.001 | F(1,134) = 39.76 | Time | <.001 |
TAU | 97 | 139.4 (31.4) | 60 | 133.8 (34.9) | 0.32 | .02 | 97 | 135.1 (32.2) | 0.25 | <.001 | F(1,34) = 0.026 | Group | .871 | |
dc | 0.60 | .02 | 0.30 | .11 | F(1,134) = 19.19 | Gr. x ti. | <.001 |
Cohen’s d was computed using the pooled standard deviation of scores at admission (t1) and discharge (t2).
Repeated measures analysis of variance with intent to treat data.
Cohen’s d was computed using the pooled standard deviation of scores at discharge (t2) from the DBT-PTSD and TAU groups.